MONROVIA, Calif., Feb. 13 /PRNewswire-FirstCall/ -- STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will present at the Roth Capital Partners 19th Annual OC Conference, which will take place at the Ritz-Carlton Laguna Niguel. The Company is scheduled to discuss its business strategy and historical financial performance on Tuesday, February 20, 2007, at 2:00 p.m. Pacific Time.
Attendance at the conference is by invitation only. A live audio webcast of STAAR’s presentation may be accessed through the Company’s website at www.staar.com. An archived replay of the presentation will be available after the live presentation and can also be accessed at www.staar.com for 90 days.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR’s ICL is approved by the FDA for use in treating myopia, has received CE Marking and is approved for sale in 43 countries. More than 65,000 ICLs have been sold worldwide. More information is available at www.staar.com.
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Jen Saunders, 646-201-5431 Jennifer Beugelmans, 646-201-5445
STAAR Surgical Company
CONTACT: Investors, Douglas Sherk, +1-415-896-6820, or JenniferBeugelmans, +1-646-201-5445, or Media, Jen Saunders, +1-646-201-5431, allof EVC Group for STAAR Surgical Company
Web site: http://www.staar.com/
